Table 1.
The effect of sodium selenite on serum, liver, and kidney GPX activity in alloxan-induced diabetic rats (Values represented as mean ± S.D).
| Experimental groups | Serum | Kidney | Liver | |
|---|---|---|---|---|
| GPX activity (U/mg protein) |
Control (non-diabetic untreated) | 69.19 ± 20.11* | 66.92 ± 8.25* | 63.52 ± 13.30* |
| Non-diabetic treated | 70.86 ± 13.76* | 70.16 ± 5.11* | 68.67 ± 13.33* | |
| Diabetic untreated | 44.86 ± 10.89 | 37.06 ± 16.49 | 42.77 ± 6.78 | |
| Diabetic treated | 52.241 ± 13.76 # | 65.04 ± 7.73* | 52.45 ± 15.99* #√ | |
*
P < .05 compared with diabetic untreated group.
#
P < .05 compared with controls.
√
P < .05 compared with the non diabetic treated group.